cytarabine has been researched along with clobetasol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Argenyi, Z; Hurst, S; Olerud, J; Tran, DT; Wolgamot, GM | 1 |
2 other study(ies) available for cytarabine and clobetasol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
An 'eruptive' variant of juvenile xanthogranuloma associated with langerhans cell histiocytosis.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Clobetasol; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Methotrexate; Prednisone; Vincristine; Xanthogranuloma, Juvenile | 2008 |